Newer Compounds in Therapy of Herpes Simplex Keratitis
- 1 November 1967
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 78 (5), 600-605
- https://doi.org/10.1001/archopht.1967.00980030602008
Abstract
The antiviral activity of idoxuridine (5-iodo-2'deoxyuridine, IDU), trifluorothymidine (F3TDR), and 5-methylamino-2'deoxyuridine (MADU) were compared on a double-blind basis by noting the effect of topical administration of the drugs on the severity of epithelial herpetic keratitis in rabbits. F3TDR was clearly more effective in eliminating herpetic lesions than either idoxuridine or MADU. The virus content of infected corneas was determined while under treatment with idoxuridine and F3TDR, after antiviral treatment, and throughout placebo treatment. The F3TDR was more effective in lowering the virus titer, and this lowering appeared to be correlated with the epithelial healing. Prolonged treatment prevented a rise in virus titer, which had been seen after shorter periods of idoxuridine therapy. There was no evidence of corneal toxicity after treatment with high concentration of F3TDR in man and animals.This publication has 2 references indexed in Scilit:
- STUDIES ON HERPES SIMPLEX .11. ANTIVIRAL DYNAMICS OF 5-IODO-2-DEOXYURIDINE IN VIVO1965
- Syntheses of 5-Trifluoromethyluracil and 5-Trifluoromethyl-2'-deoxyuridine1,2Journal of Medicinal Chemistry, 1964